Gemtuzumab Ozogamicin Plus Midostaurin in Combination with Standard Intensive Induction Therapy in Newly Diagnosed AML: Results from a Phase-I Study
Christoph Röllig,Christoph Schliemann,Jan-Henrik Mikesch,Lars Fransecky,Claudia D. Baldus, Björn-Niklas Heydrich,Maher Hanoun,Richard Noppeney,Sebastian Scholl,Ulf Schnetzke,Kerstin Schäfer-Eckart,Knut Wendelin,Martin Wermke, Manja Reimann,Frank Fiebig,Theresa Kretschmann,Friedrich Stoelzel,Nael Alakel,Martin Bornhäuser Blood(2021)
AI 理解论文
溯源树
样例